Biz Hugo Bellen ve reaktifler için Bloomington Stok Merkezi teşekkür etmek istiyorum. Biz daha yararlı tartışmalar için Koen Venken, Hugo Bellen ve Buszczak ve Hiesinger laboratuarları tüm üyeleri teşekkür ederiz. Bu çalışma ACR için Ulusal Sağlık Enstitüsü (T32GM083831), PRH (RO1EY018884) hibe tarafından ve MB (RO1GM086647), MB ve PRH (RP100516) için Texas Kanser Önleme Araştırma Enstitüsü tarafından hibe ve Welch için desteklenmiştir PRH için Vakfı (I-1657). MB Biyomedikal Araştırma ve PRH bir EE ve Greer Garson Fogelson Akademik olan UT Güneybatı Tıp Merkezi Biyomedikal Araştırma bir Eugene McDermott Akademik olduğunu.

<ol>
	<li>Rong, Y. S., Golic, K. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+targeted+gene+knockout+in+Drosophila.">A targeted gene knockout in Drosophila.</a> Genetics. 157, 1307-1312 (2001).</li><li>Rong, Y. S., Golic, K. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gene+targeting+by+homologous+recombination+in+Drosophila.">Gene targeting by homologous recombination in Drosophila.</a> Science. 288, 2013-2018 (2000).</li><li>Gong, W. J., Golic, K. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ends-out,+or+replacement,+gene+targeting+in+Drosophila.">Ends-out, or replacement, gene targeting in Drosophila.</a> Proc. Natl. Acad. Sci. U.S.A. 100, 2556-2561 (1073).</li><li>Warming, S., Costantino, N., Court, D. L., Jenkins, N. A., Copeland, N. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Simple+and+highly+efficient+BAC+recombineering+using+galK+selection.">Simple and highly efficient BAC recombineering using galK selection.</a> Nucleic Acids Res. 33, e36 (2005).</li><li>Copeland, N. G., Jenkins, N. A., Court, D. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Recombineering:+a+powerful+new+tool+for+mouse+functional+genomics.">Recombineering: a powerful new tool for mouse functional genomics.</a> Nat. Rev. Genet. 2, 769-779 (2001).</li><li>Venken, K. J., He, Y., Hoskins, R. A., Bellen, H. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=P[acman]:+a+BAC+transgenic+platform+for+targeted+insertion+of+large+DNA+fragments+in+D.+melanogaster.">P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster.</a> Science. 314, 1747-1751 (2006).</li><li>Venken, K. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Versatile+P[acman]+BAC+libraries+for+transgenesis+studies+in+Drosophila+melanogaster.">Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster.</a> Nat. Methods. 6, 431-434 (2009).</li><li>Groth, A. C., Fish, M., Nusse, R., Calos, M. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Construction+of+transgenic+Drosophila+by+using+the+site-specific+integrase+from+phage+phiC31.">Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31.</a> Genetics. 166, 1775-1782 (2004).</li><li>Bischof, J., Maeda, R. K., Hediger, M., Karch, F., Basler, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+optimized+transgenesis+system+for+Drosophila+using+germ-line-specific+phiC31+integrases.">An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases.</a> Proceedings of the National Academy of Sciences of the United States of America. 104, 3312-3317 (2007).</li><li>Chan, C. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Systematic+discovery+of+Rab+GTPases+with+synaptic+functions+in+Drosophila.">Systematic discovery of Rab GTPases with synaptic functions in Drosophila.</a> Current Biology: CB. 21, 1704-1715 (2011).</li><li>Chan, C. C., Scoggin, S., Hiesinger, P. R., Buszczak, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Combining+recombineering+and+ends-out+homologous+recombination+to+systematically+characterize+Drosophila+gene+families:+Rab+GTPases+as+a+case+study.">Combining recombineering and ends-out homologous recombination to systematically characterize Drosophila gene families: Rab GTPases as a case study.</a> Commun. Integr. Biol. 5, 179-183 (2012).</li><li>Wu, N., Matand, K., Kebede, B., Acquaah, G., Williams, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhancing+DNA+electrotransformation+efficiency+in+Escherichia+coli+DH10B+electrocompetent+cells.">Enhancing DNA electrotransformation efficiency in Escherichia coli DH10B electrocompetent cells.</a> Electronic Journal of Biotechnology. 13, (2010).</li><li>Wang, S., Zhao, Y., Leiby, M., Zhu, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+new+positive/negative+selection+scheme+for+precise+BAC+recombineering.">A new positive/negative selection scheme for precise BAC recombineering.</a> Mol. Biotechnol. 42, 110-116 (2009).</li><li>Venken, K. J., Bellen, H. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transgenesis+upgrades+for+Drosophila+melanogaster.">Transgenesis upgrades for Drosophila melanogaster.</a> Development. 134, 3571-3584 (2007).</li><li>Dietzl, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+genome-wide+transgenic+RNAi+library+for+conditional+gene+inactivation+in+Drosophila.">A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila.</a> Nature. 448, 151-156 (2007).</li></ol>

Yazarlar burada özetlenen teknikleri ile ilgili herhangi bir çıkar çatışması yok.

Biyomedikal araştırmalarda genetik model organizmaların gücü büyük ölçüde genetik manipülasyon için mevcut araçları dayanmaktadır. Küçük modelleri C. Özellikle elegans ve Drosophila çok hücreli geliştirme veya fonksiyon rol tam yollar ve gen ailelerin ucuz ve hızlı moleküler genetik analizler için izin verir. Son yıllarda Drosophila 14,15 genlerin işlemek için araç gelişiminde önemli gelişmeler gördük. Örneğin yaygın olarak kullanılan ...

Kendi endojen bölgelerinin tek genlerin moleküler tanımlı manipülasyonlar temizlemek ökaryot biyoloji ile ilgili soru sayısız incelemek için paha biçilmez bir araç sunuyor. Drosophila kaybı fonksiyon-allel üretmek için genetik teknikleri ters Golic ve arkadaşları tanıtıldı kadar zorlu olduğu kanıtlanmış oldu İn vivo gen Drosophila 1-3 ile homolog rekombinasyon kullanılarak hedefleme. Bu, belirli bir genomik lokus entegre bir yapı transgenik DNA doğrusal bir fragmanı kullanılarak hedef olabilir gösterdi. Bu doğrusal &quot;donör DNA&quot; meganuclease I-SCEI ile doğrusal takip FRT-aracılı rekombinasyon (tüketim için dairesel bir molekül olarak kromozom DNA) ile in vivo olarak oluşturulur. Bu yöntem başarılı bir şekilde tanımlanan lezyonların çeşitli oluşturmak için kullanılmış olsa da, bu teknik paralel çok sayıda gen manipülasyonu için kolayca ölçeklenebilir olmamıştır, çünkü her vermemekÇift eleme yapı farklı ve özel tasarım gerektirir. Örneğin, sorunsuz bir şekilde klasik bir kısıtlama enzimi / ligasyon klonlama veya PCR, hem de in vivo transformasyon vektörleri de geleneksel boyut sınırlamaları kullanılarak in vitro olarak DNA (&gt; 5 kb) arasında büyük parçaları manipüle güçlükler çoğu hedefleme homolog rekombinasyon hızla oluşmasına müdahale vektörler. Bu sınırlamaları aşmak için, uçları aşımı geni etkin ve nispeten hızlı bir platform kurmak için metodoloji hedef ile, DNA&#39;nın 100 kb kadar alt klonlama ve transgenesis sağlar Recombineering / transgenesis P [ACMAN] sistemi, kombine Drosophila gen hedef kolaylaştırır. Rekombinasyon aracılı genetik mühendisliği (Recombineering) 4,5 güçlü bir homolog rekombinasyon bazlı klonlama teknolojidir. Geleneksel sınırlama enzim / ligaz klonlama aksine, Recombineering sırası veya siz ile sınırlı değildirmanipüle DNA e. Recombineering özel E. kullanır kusurlu bir λ profajının 4 tarafından sağlanan rekombinasyon makine barındırır coli. Bu teknik son zamanlarda Drosophila 6,7 kullanılmak üzere kabul edilmiştir. Drosophila Recombineering P [ACMAN] 6,7 adlı değiştirilmiş bir şartlı çoğaltılabilir bakteriyel yapay kromozom (BAC) vektör dayanır. OriV, sekanslama ve embriyo enjeksiyon ve bazal koşullar altında, düşük kopya sayısı, tutar ORIS için gerekli DNA büyük miktarlarda saflaştırılması için kimyasal indüksiyon üzerine yüksek kopya sayısında üretir: Bu vektör, replikasyon kökeni iki taşır. Ayrıca, P [ACMAN] Vektör bakteriyel bir eki (attB) sitesi ile donatılmıştır. AttB Alanı Drosophila 8,9 genomu içinde önceden tespit edilmiş bir iniş yeri içine büyük DNA parçalarının birleşme sağlar ΦC31 integraz aracılı transgenezis için bir alt-tabaka olarak hizmet vermektedir. Bu sona Çıkış homolog rekombinasyon 10,11 için bir hedefleme vektörü olarak kullanılabilecek bir p [ACMAN] vektörü (p [ACMAN]-KO, 1.0 olarak anılacaktır) üretmiştir. Sisteme hedefleme teknolojisi dahil biter-out gen, iki ÖN ve iki I-SCEI siteleri ekledi. Ayrıca P [ACMAN]-KO 1.0 içine homoloji silah içeren süreci kolaylaştırmak için bu modifiye vektör içinde bir ağ geçidi kaset dahil ettik. Bu hedef vektör içine ilgi hemen hemen her genomik bölge tanıtmak için hızlı ve kolay bir yol sağlar. Bu protokolde P [ACMAN]-KO 1.0, ve nasıl endojen odağı hedef in vivo olarak bu vektör harekete geçirmek için kullanarak bir hedef vektör mühendisi nasıl anlatacağız. Bu protokolün amaçla, ilgili genin yerine RFP / Kan kaseti kullanır, ancak bir antibiyotik seçim işaretleyici içeren kasetlerinin çeşitli Bu protokol kullanılabilir. Bu kaset, bir dizi için tasarlanmış ve başarılı bir şekilde kullanılmışgen değiştirme ve etiketleme 10,11.

<table border="1">
	<tbody>
		<tr>
			<td>Name of the reagent</td>
			<td>Company</td>
			<td>Catalogue number</td>
			<td>Comments (optional)</td>
		</tr>
		<tr>
			<td>SW102 Recombination competent bacteria</td>
			<td>NCI-Frederick</td>
			<td>Recombination Bacteria (SW102, SW105 and SW106)</td>
			<td><a href="http://ncifrederick.cancer.gov/research/brb/logon.aspx" target="_blank">http://ncifrederick.cancer.gov/research/brb/logon.aspx</a></td>
		</tr>
		<tr>
			<td>TransforMax EPI300 electrocopmpetent E. coli</td>
			<td>Epicentre</td>
			<td>EC300110</td>
			<td>Includes CopyControl induction solution</td>
		</tr>
		<tr>
			<td>PfuUltra II Fusion HS DNA Polymerase</td>
			<td>Aligent Technology Inc.</td>
			<td>600670</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>BamHI-HF</td>
			<td>New England Biolabs</td>
			<td>R3136S</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Zymoclean Gel DNA Recovery Kit</td>
			<td>Zymo Research</td>
			<td>D4001</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Use Gateway BP ClonaseII Enzyme kit</td>
			<td>Invitrogen</td>
			<td>11789-020</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>P[acman]KO1.010</td>
			<td>Buszczak and Hiesinger Labs</td>
			<td>Upon request</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>pENTR RFP-Kan11</td>
			<td>Buszczak and Hiesinger Labs</td>
			<td>Upon request</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Flystocks</td>
			<td>Bloomington stock center</td>
			<td>Stock numbers: 25680, 25679</td>
			<td>y1 w*/Dp(2;Y)G, P{hs-hid}Y; P{70FLP}11 P{70I-SceI}2B snaSco/CyO, P{hs-hid}4 
			y1 w*/Dp(2;Y)G, P{hs-hid}Y; P{70FLP}23 P{70I-SceI}4A/TM3, P{hs-hid}14, Sb1</td>
		</tr>
		<tr>
			<td>Electroporation machine</td>
			<td>Biorad GenePulser Xcell with PC module</td>
			<td>165-2662</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Cuvettes</td>
			<td>Fisher Brand</td>
			<td>#FB101</td>
			<td>&nbsp;</td>
		</tr>
	</tbody>
</table>

recombineering homologous recombination constructs in drosophila

Endojen gen loci hızlı, büyük ölçekli manipülasyon teknikleri sürekli gelişimi insan hastalığı ile ilgili araştırmalar için bir genetik model organizma olarak Drosophila melanogaster kullanımını genişletecek. Son yıllarda homolog rekombinasyon ve Recombineering gibi teknik gelişmeler gördük. Ancak, kesin boş mutasyonlar veya etiketleme endojen proteinleri üreten genlerin çoğu için önemli bir çaba olmaya devam etmektedir. Burada, in vivo olarak endojen loci hedef ve işlemek için kullanılabilir vektörler oluşturmak için Recombineering tabanlı klonlama yöntemleri kullanarak teknikleri tarif ve göstermek Özellikle, üç teknolojileri bir arada kurduk:. (1) BAC transgenesis / Recombineering, ( 2) biter-out homolog rekombinasyon ve (3) Ağ Geçidi teknolojisi endojen genomik lokus işlemek için sağlam, verimli ve esnek bir yöntem sağlamaktır. Bu protokol, nasıl (1) tasarım individua hakkında adım adım ayrıntılarıl vektörleri, (2) boşluk tamir, ve (3) nasıl Recombineering bir ikinci tur kullanarak bu vektörlerin içinde ilgi genleri değiştirmek veya etiketlemek için kullanarak homolog rekombinasyon vektörü genomik DNA büyük parçaları klonlamak için nasıl. Son olarak, biz de bir nakavt, veya knock-in üzeri etiketli gen oluşturmak için in vivo olarak bu kasetleri harekete geçirmek için nasıl bir protokol sağlayacaktır. Bu yöntemler kolayca paralel olarak birden çok hedef için kabul edilen ve zamanında ve verimli bir şekilde Drosophila genom işlemek için bir araç sağlamak olabilir.

LA ve RA homoloji silah yükseltme 500 bp ürünler üretmek gerektiğini ve PCR-KİT reaksiyon 1.0 kb ürün (Bölüm 2,1-2,4; Şekil 2) boyun eğmek zorundadır. 2.5 bölümünde gerçekleştirilen BP reaksiyon tipik ürün verimleri ortalama 5-100 kolonilerin çok verimli ve bakteriyel bir dönüşümdür. Yaklaşık PCR ile test bütün sömürgeler beklenen PCR ürün göstermek kontrol edin. Recombineering ilk turda (Bölüm 3) sırasında sindirilmiş P dönüşüm so...

Watch this Scientific Journal Video about Recombineering Homologous Recombination Constructs in Drosophila at JoVE.com

Recombineering Homologous Recombination Constructs in Drosophila

Homolog rekombinasyon teknikleri büyük ölçüde ilerletmek<em&gt; Drosophila</em&gt; Moleküler kesin mutasyon oluşturulması sağlayarak genetik. Recombineering kabul edilen son bir DNA büyük parça işlemek ve onları dönüştürmek sağlar<em&gt; Drosophila</em<sup&gt; 6</sup&gt;. Yöntemleri, hızla büyük bir homolog rekombinasyon vektörleri oluşturmak için bu teknikleri birleştirmek Burada yer.

Homolog rekombinasyon Oluşumlar Recombineering<em&gt; Drosophila</em

The continued development of techniques for fast, large-scale manipulation of endogenous gene loci will broaden the use of Drosophila melanogaster as a ...

recombineering-homologous-recombination-constructs-in-drosophila

Research

JoVE Journal

Biology

Recombineering Homologous Recombination Constructs in Drosophila

19.1K Görüntüleme.  University of Texas Southwestern Medical Center at Dallas. Homolog rekombinasyon teknikleri büyük ölçüde ilerletmek Drosophila Moleküler kesin mutasyon oluşturulması sağlayarak genetik. Recombineering kabul edilen son bir DNA büyük parça işlemek ve onları dönüştürmek sağlar Drosophila

Video: Recombineering Homologous Recombination Constructs in Drosophila

Wolbachia Bacterial Infection in Drosophila

My name is Voia Friedman. I am associate researcher at Princeton University. And today I'm going to tell you about a few protocols that I developed to trans infect, to I initially to isolate, to go back from the heli of infected flies, and later on help to inject the heli feed to unaffected flights.So basically, this is a very simple protocol to isolate him oly for basics. And you will use this device from, from mepo that contains a filter that goes on top of an E.So you basically needs to put you, we start from around a hundred flies. You anize the flies, you put them into the filter device, you can just use a funnel and that will add our other fit very easily on this device and wash it with 70%ethanol.You just take the, take the future away, you can throw away the ethanol, and then after three times your last wash you do with molecule water because you don't want have the bacteria from the, with traces of ethanol. Well, and then you just go to a new weapon door and, and then you spin down on a micro, real micro for two minutes And later on how you can inject that. He only feed do unaffected flies.So basically take a double stick tape and usually these double stick tapes have two side, one side is a sticker than the other. So leave the sticker side up because that's the side that you're gonna glue that flies on top of it. And basically you'll, the gas apparatus, if you have this light on top of it, you'll be no gas flow and the flies you wake up if they're on top of the slide.So you can just direct the flow, making a little hood, a little chamber using tape. Then you direct the gas over the flies. So then you put your, this light here with the tape and you, you have your flies.Stick the flies on the top of the tape, all of them the same orientation, and put their head towards the direction that you'll be bringing the needle from. Because then you can just over the, the wing, you make sure since they fly, you don't want to fly. If they woke up during the procedure, don't want them to go away.So make sure that you take a little tip and pressure against the, the, the wings of the fly on the tail. And it's okay if they wings get damaged. And when you get rid, when you take the flies up the injection, most likely they'll lose their wings anyway, so they'll survive.That can, that can be useful because you're not gonna lose the flies that, so he puts a mineral oil on the micrometer for the back of the needle, then the needle injection polar, and then the, you can just adjust the pressure to bring the material up to the tip of the needle. I, I did to inject Somewhere between 10 to 15 nanoliters, but as, as long, as long as I'm consistents. Okay, so one important detail there is a cushion of this experiment is that the, the fly, once the apply is being injected when you saw the needle needs to come as far as you can through the upper part of the abdomen.Because here, basically when the needle penetrates, you have a, a, a, a, a bigger space to go up and down. And basically if it's close, closer to the cuticle, it's less likely they're gonna penetrate vital organs in the flight. You, it is very likely unlikely that you're gonna punch a hole in your gut, for instance, if that is gonna kill the flight that you are performing the surgery.My name is Voia Friedman. I am associate researcher at Princeton University in the lab of Eric Hels. And today I would like to tell you about this protocol that you just saw, the demonstration.So this protocol was done because we wanted to prove that UBA is capable of crossing tissues. So UBA is one of the most successful intracellular paras on the face of the earth. Infects from 20 to 70%of insects and many particles.And also is, is very important in terms of human diseases because also infect nematodes that transmit diseases like river blindness or s and ssis. And so, and CCA is our obligatory endo in, in these worms. And there's a great, a very big interest in using CCA also as means to control parasitic diseases transmitter by mosquito and Danny and this and by mosquito such as malaria and dengue.So this, this, this protocol basically was developed to show that once CCA inside the abdominal cavity of a fly, they can cross tissues and reach the germ. So basically what you can see here is the oph of the drosophila ovary and go back once present in the he leaf it, it can cross a pink peronial. She that is around the ovary.And then they cross a muscle layer. And actually one of the first places that they, they go inside the ovary is the somatic stem cell image. And then they can reach the germline.And this bacteria is transmitted the same way that mitochondria is transmitted is through, is through the mother transmitted, through the mother cyop plants present in the egg. So of course they needs to be present into the germline. So that's why this protocol is developed.And this protocol is, can be very useful to basically traditionally the way that people would try to trans infect wbaa basically take wbaa and introduce a new insect species. It would be through doing micro injections into the, into the embryo. But those are much more complicated.And basically here we are just taking advantage of the o biology since they are capable to cross tissues and moving into the stem cell tissues from, they can pass to the, through to the germline. So that's make easier taking UBA from certain, from, from certain species of insects that are infected and they can be transmitted to uninfected species. Prob I think it's the injection itself.Basically you need to be careful to mobilize the fly as well as you can. We are using double sided stick tape and you need to penetrate the needle basically as close to the, as parallel to the fly as possible so you don't go to deep. And it's less likely that we're gonna kill the fly after they're performing the surgery.

Drosophila Wolbachia Bakteriyel Enfeksiyon

Biyoloji

Fabrication of Myogenic Engineered Tissue Constructs

Despite the fact that electronic pacemakers are life-saving medical devices, their long-term performance in pediatric patients can be problematic owing to the restrictions imposed by a child's small size and their inevitable growth. Consequently, there is a genuine need for innovative therapies designed specifically for pediatric patients with cardiac rhythm disorders. We propose that a conductive biological alternative consisting of a collagen-based matrix containing autologously-derived cells could better adapt to growth, reduce the need for recurrent surgeries, and greatly improve the quality of life for these patients. In the present study, we describe a procedure for incorporating primary skeletal myoblast cell cultures within a hydrogel matrix to fashion a surgically-implantable tissue construct that will serve as an electrical conduit between the upper and lower chambers of the heart. Ultimately, we anticipate using this type of engineered tissue to restore atrioventricular electrical conduction in children with complete heart block. In view of that, we isolate myoblasts from the skeletal muscles of neonatal Lewis rats and plate them onto laminin-coated tissue culture dishes using a modified version of established protocols[2, 3]. After one to two days, cultured cells are collected and mixed with antibiotics, type 1 collagen, Matrigel&trade;, and NaHCO3. The result is a viscous, uniform solution that can be cast into a mold of nearly any shape and size[1, 4, 5]. For our tissue constructs, we employ type 1 collagen isolated from fetal lamb skin using standard procedures[6]. Once the tissue has solidified at 37&deg;C, culture media is carefully added to the plate until the construct is submerged. The engineered tissue is then allowed to further condense through dehydration for 2 more days, at which point it is ready for in vitro assessment or surgical-implantation.

Here, we demonstrate fabrication of collagen-based, tissue constructs containing skeletal myoblasts. These 3-D engineered constructs may be used to replace or repair tissues in vivo. For our purposes, we have designed these as an atrioventricular electrical conduit for the repair of complete heart block[1].

MİYOJEN Engineered Doku oluşturur imalatı

Despite the fact that electronic pacemakers are life-saving medical devices, their long-term performance in pediatric patients can be problematic owing to ...

The Production of C. elegans Transgenes via Recombineering with the galK Selectable Marker

The creation of transgenic animals is widely utilized in C. elegans research including the use of GFP fusion proteins to study the regulation and expression pattern of genes of interest or generation of tandem affinity purification (TAP) tagged versions of specific genes to facilitate their purification. Typically transgenes are generated by placing a promoter upstream of a GFP reporter gene or cDNA of interest, and this often produces a representative expression pattern. However, critical elements of gene regulation, such as control elements in the 3' untranslated region or alternative promoters, could be missed by this approach. Further only a single splice variant can be usually studied by this means. In contrast, the use of worm genomic DNA carried by fosmid DNA clones likely includes most if not all elements involved in gene regulation in vivo which permits the greater ability to capture the genuine expression pattern and timing. To facilitate the generation of transgenes using fosmid DNA, we describe an E. coli based recombineering procedure to insert GFP, a TAP-tag, or other sequences of interest into any location in the gene. The procedure uses the galK gene as the selection marker for both the positive and negative selection steps in recombineering which results in obtaining the desired modification with high efficiency. Further, plasmids containing the galK gene flanked by homology arms to commonly used GFP and TAP fusion genes are available which reduce the cost of oligos by 50% when generating a GFP or TAP fusion protein. These plasmids use the R6K replication origin which precludes the need for extensive PCR product purification. Finally, we also demonstrate a technique to integrate the unc-119 marker on to the fosmid backbone which allows the fosmid to be directly injected or bombarded into worms to generate transgenic animals. This video demonstrates the procedures involved in generating a transgene via recombineering using this method.

The Production of C. elegans Transgenes via Recombineering with the galK Selectable Marker

The ability to produce transgenes for Caenorhabditis elegans using genomic DNA carried by fosmids is particularly attractive as all of the native regulatory elements are retained. Described is a simple and robust procedure for the production of transgenes via recombineering with the galK selectable marker.

Üretimi C. elegans Recombineering yoluyla transgenlerin GalK Seçilebilir Marker

The creation of transgenic animals is widely utilized in C. elegans research including the use of GFP fusion proteins to study the regulation and ...

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

The functional analysis of missense mutations can be complicated by the presence in the cell of the endogenous protein. Structure-function analyses of the BRCA1 have been complicated by the lack of a robust assay for the full length BRCA1 protein and the difficulties inherent in working with cell lines that express hypomorphic BRCA1 protein1,2,3,4,5. We developed a system whereby the endogenous BRCA1 protein in a cell was acutely depleted by RNAi targeting the 3'-UTR of the BRCA1 mRNA and replaced by co-transfecting a plasmid expressing a BRCA1 variant. One advantage of this procedure is that the acute silencing of BRCA1 and simultaneous replacement allow the cells to grow without secondary mutations or adaptations that might arise over time to compensate for the loss of BRCA1 function. This depletion and add-back procedure was done in a HeLa-derived cell line that was readily assayed for homologous recombination activity. The homologous recombination assay is based on a previously published method whereby a recombination substrate is integrated into the genome (Figure 1)6,7,8,9. This recombination substrate has the rare-cutting I-SceI restriction enzyme site inside an inactive GFP allele, and downstream is a second inactive GFP allele. Transfection of the plasmid that expresses I-SceI results in a double-stranded break, which may be repaired by homologous recombination, and if homologous recombination does repair the break it creates an active GFP allele that is readily scored by flow cytometry for GFP protein expression. Depletion of endogenous BRCA1 resulted in an 8-10-fold reduction in homologous recombination activity, and add-back of wild-type plasmid fully restored homologous recombination function. When specific point mutants of full length BRCA1 were expressed from co-transfected plasmids, the effect of the specific missense mutant could be scored. As an example, the expression of the BRCA1(M18T) protein, a variant of unknown clinical significance10, was expressed in these cells, it failed to restore BRCA1-dependent homologous recombination. By contrast, expression of another variant, also of unknown significance, BRCA1(I21V) fully restored BRCA1-dependent homologous recombination function. This strategy of testing the function of BRCA1 missense mutations has been applied to another biological system assaying for centrosome function (Kais et al, unpublished observations). Overall, this approach is suitable for the analysis of missense mutants in any gene that must be analyzed recessively.

We provide a method for testing BRCA1 variants in a tissue culture based assay for homologous recombination repair of DNA damage by depleting endogenous BRCA1 protein from a cell using RNAi and replacing it with a BRCA1 point mutant that contains a coding change.

Endojen Wild-tip BRCA1 Express hücreler kullanarak Homolog Rekombinasyon BRCA1 Mutasyonlar Etkileri belirlenmesi

The functional analysis of missense mutations can be complicated by the presence in the cell of the endogenous protein. Structure-function analyses of the ...

Imaging Cell Shape Change in Living Drosophila Embryos

The developing Drosophila melanogaster embryo undergoes a number of cell shape changes that are highly amenable to live confocal imaging. Cell shape changes in the fly are analogous to those in higher organisms, and they drive tissue morphogenesis. So, in many cases, their study has direct implications for understanding human disease (Table 1)1-5. On the sub-cellular scale, these cell shape changes are the product of activities ranging from gene expression to signal transduction, cell polarity, cytoskeletal remodeling and membrane trafficking. Thus, the Drosophila embryo provides not only the context to evaluate cell shape changes as they relate to tissue morphogenesis, but also offers a completely physiological environment to study the sub-cellular activities that shape cells.
The protocol described here is designed to image a specific cell shape change called cellularization. Cellularization is a process of dramatic plasma membrane growth, and it ultimately converts the syncytial embryo into the cellular blastoderm. That is, at interphase of mitotic cycle 14, the plasma membrane simultaneously invaginates around each of ~6000 cortically anchored nuclei to generate a sheet of primary epithelial cells. Counter to previous suggestions, cellularization is not driven by Myosin-2 contractility6, but is instead fueled largely by exocytosis of membrane from internal stores7. Thus, cellularization is an excellent system for studying membrane trafficking during cell shape changes that require plasma membrane invagination or expansion, such as cytokinesis or transverse-tubule (T-tubule) morphogenesis in muscle.
Note that this protocol is easily applied to the imaging of other cell shape changes in the fly embryo, and only requires slight adaptations such as changing the stage of embryo collection, or using "embryo glue" to mount the embryo in a specific orientation (Table 1)8-19. In all cases, the workflow is basically the same (Figure 1). Standard methods for cloning and Drosophila transgenesis are used to prepare stable fly stocks that express a protein of interest, fused to Green Fluorescent Protein (GFP) or its variants, and these flies provide a renewable source of embryos. Alternatively, fluorescent proteins/probes are directly introduced into fly embryos via straightforward micro-injection techniques9-10. Then, depending on the developmental event and cell shape change to be imaged, embryos are collected and staged by morphology on a dissecting microscope, and finally positioned and mounted for time-lapse imaging on a confocal microscope.

Imaging Cell Shape Change in Living Drosophila Embryos

Early development of the fruit fly, Drosophila melanogaster, is characterized by a number of cell shape changes that are well suited for imaging approaches. This article will describe basic tools and methods required for live confocal imaging of Drosophila embryos, and will focus on a cell shape change called cellularization.

Living Görüntüleme Hücre Şekli Değiştir Drosophila Embriyolar

The developing Drosophila melanogaster embryo undergoes a number of cell shape changes that are highly amenable to live confocal imaging.  Cell shape ...

Genetic Modification and Recombination of Salivary Gland Organ Cultures

Branching morphogenesis occurs during the development of many organs, and the embryonic mouse submandibular gland (SMG) is a classical model for the study of branching morphogenesis. In the developing SMG, this process involves iterative steps of epithelial bud and duct formation, to ultimately give rise to a complex branched network of acini and ducts, which serve to produce and modify/transport the saliva, respectively, into the oral cavity1-3. The epithelial-associated basement membrane and aspects of the mesenchymal compartment, including the mesenchyme cells, growth factors and the extracellular matrix, produced by these cells, are critical to the branching mechanism, although how the cellular and molecular events are coordinated remains poorly understood 4. The study of the molecular mechanisms driving epithelial morphogenesis advances our understanding of developmental mechanisms and provides insight into possible regenerative medicine approaches. Such studies have been hampered due to the lack of effective methods for genetic manipulation of the salivary epithelium. Currently, adenoviral transduction represents the most effective method for targeting epithelial cells in adult glands in vivo5. However, in embryonic explants, dense mesenchyme and the basement membrane surrounding the epithelial cells impedes viral access to the epithelial cells. If the mesenchyme is removed, the epithelium can be transfected using adenoviruses, and epithelial rudiments can resume branching morphogenesis in the presence of Matrigel or laminin-1116,7. Mesenchyme-free epithelial rudiment growth also requires additional supplementation with soluble growth factors and does not fully recapitulate branching morphogenesis as it occurs in intact glands8. Here we describe a technique which facilitates adenoviral transduction of epithelial cells and culture of the transfected epithelium with associated mesenchyme. Following microdissection of the embryonic SMGs, removal of the mesenchyme, and viral infection of the epithelium with a GFP-containing adenovirus, we show that the epithelium spontaneously recombines with uninfected mesenchyme, recapitulating intact SMG glandular structure and branching morphogenesis. The genetically modified epithelial cell population can be easily monitored using standard fluorescence microscopy methods, if fluorescently-tagged adenoviral constructs are used. The tissue recombination method described here is currently the most effective and accessible method for transfection of epithelial cells with a wild-type or mutant vector within a complex 3D tissue construct that does not require generation of transgenic animals.

A technique to genetically manipulate epithelial cells within whole ex vivo cultured embryonic mouse submandibular glands (SMGs) using viral gene transfer is described. This method takes advantage of the innate ability of SMG epithelium and mesenchyme to spontaneously recombine after separation and infection of epithelial rudiments with adenoviral vectors.

Tükürük Bezi Organ Kültürleri Genetik Modifikasyon ve Rekombinasyon

Branching  morphogenesis occurs during the development of many organs, and the embryonic  mouse submandibular gland (SMG) is a classical model for the ...

Live Imaging of Apoptotic Cell Clearance during Drosophila Embryogenesis

The proper elimination of unwanted or aberrant cells through apoptosis and subsequent phagocytosis (apoptotic cell clearance) is crucial for normal development in all metazoan organisms. Apoptotic cell clearance is a highly dynamic process intimately associated with cell death; unengulfed apoptotic cells are barely seen in vivo under normal conditions. In order to understand the different steps of apoptotic cell clearance and to compare 'professional' phagocytes - macrophages and dendritic cells to 'non-professional' - tissue-resident neighboring cells, in vivo live imaging of the process is extremely valuable. Here we describe a protocol for studying apoptotic cell clearance in live Drosophila embryos. To follow the dynamics of different steps in phagocytosis we use specific markers for apoptotic cells and phagocytes. In addition, we can monitor two phagocyte systems in parallel: 'professional' macrophages and 'semi-professional' glia in the developing central nervous system (CNS). The method described here employs the Drosophila embryo as an excellent model for real time studies of apoptotic cell clearance.

Live Imaging of Apoptotic Cell Clearance during Drosophila Embryogenesis

Here we describe an effective method for studying dynamics of apoptotic cell clearance in vivo. This method employs live Drosophila embryos as a powerful model for monitoring phagocytosis of apoptotic cells using specific labeling of apoptotic cells and phagocytes.

Apoptotik hücresi Temizliği görüntülenmesi sırasında Canlı<em&gt; Drosophila</em&gt; Embriyo

The  proper elimination of unwanted or aberrant cells through apoptosis and  subsequent phagocytosis (apoptotic cell clearance) is crucial for normal  ...

Preparation of the Mgm101 Recombination Protein by MBP-based Tagging Strategy

The MGM101 gene was identified 20 years ago for its role in the maintenance of mitochondrial DNA. Studies from several groups have suggested that the Mgm101 protein is involved in the recombinational repair of mitochondrial DNA. Recent investigations have indicated that Mgm101 is related to the Rad52-type recombination protein family. These proteins form large oligomeric rings and promote the annealing of homologous single stranded DNA molecules. However, the characterization of Mgm101 has been hindered by the difficulty in producing the recombinant protein. Here, a reliable procedure for the preparation of recombinant Mgm101 is described. Maltose Binding Protein (MBP)-tagged Mgm101 is first expressed in Escherichia coli. The fusion protein is initially purified by amylose affinity chromatography. After being released by proteolytic cleavage, Mgm101 is separated from MBP by cationic exchange chromatography. Monodispersed Mgm101 is then obtained by size exclusion chromatography. A yield of ~0.87 mg of Mgm101 per liter of bacterial culture can be routinely obtained. The recombinant Mgm101 has minimal contamination of DNA. The prepared samples are successfully used for biochemical, structural and single particle image analyses of Mgm101. This protocol may also be used for the preparation of other large oligomeric DNA-binding proteins that may be misfolded and toxic to bacterial cells.

The yeast mitochondrial nucleoid protein, Mgm101, is a Rad52-type recombination protein that forms large oligomeric rings. A protocol is described to prepare soluble recombinant Mgm101 using the Maltose Binding Protein (MBP)-tagging strategy coupled with cation exchange and size exclusion chromatography.

MBP tabanlı Etiketleme Stratejisi Mgm101 Rekombinasyon Protein hazırlanması

The MGM101 gene was identified 20 years ago for its role in the maintenance of mitochondrial DNA. Studies from several groups have suggested that the ...

Subcloning Plus Insertion (SPI) - A Novel Recombineering Method for the Rapid Construction of Gene Targeting Vectors

Gene targeting refers to the precise modification of a genetic locus using homologous recombination. The generation of novel cell lines and transgenic mouse models using this method necessitates the construction of a &#8216;targeting&#8217; vector, which contains homologous DNA sequences to the target gene, and has for many years been a limiting step in the process. Vector construction can be performed in vivo in Escherichia coli cells using homologous recombination mediated by phage recombinases using a technique termed recombineering. Recombineering is the preferred technique to subclone the long homology sequences (>4kb) and various targeting elements including selection markers that are required to mediate efficient allelic exchange between a targeting vector and its cognate genomic locus. Typical recombineering protocols follow an iterative scheme of step-wise integration of the targeting elements and require intermediate purification and transformation steps. Here, we present a novel recombineering methodology of vector assembly using a multiplex approach. Plasmid gap repair is performed by the simultaneous capture of genomic sequence from mouse Bacterial Artificial Chromosome libraries and the insertion of dual bacterial and mammalian selection markers. This subcloning plus insertion method is highly efficient and yields a majority of correct recombinants. We present data for the construction of different types of conditional gene knockout, or knock-in, vectors and BAC reporter vectors that have been constructed using this method. SPI vector construction greatly extends the repertoire of the recombineering toolbox and provides a simple, rapid and cost-effective method of constructing these highly complex vectors.

Subcloning Plus Insertion SPI - A Novel Recombineering Method for the Rapid Construction of Gene Targeting Vectors

Gene targeting methodologies can be used to generate transgenic mice with knockout, knock-in and tagged alleles. Here, we describe an improved method of recombineering in E. coli, that we term &#8216;subcloning plus insertion&#8217;, which can be used to generate custom gene targeting vectors rapidly.

Alt klonlama Artı Ekleme (SPI) - Gen Hedefleme Vektörler Rapid İnşaat için Yeni Bir Yöntem Recombineering

Gene targeting refers to the precise modification of a genetic locus using homologous recombination. The generation of novel cell lines and transgenic ...

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

RNA-mediated knockdowns are widely used to control gene expression. This versatile family of techniques makes use of short RNA (sRNA) that can be synthesized with any sequence and designed to complement any gene targeted for silencing. Because sRNA constructs can be introduced to many cell types directly or using a variety of vectors, gene expression can be repressed in living cells without laborious genetic modification. The most common RNA knockdown technology, RNA interference (RNAi), makes use of the endogenous RNA-induced silencing complex (RISC) to mediate sequence recognition and cleavage of the target mRNA. Applications of this technique are therefore limited to RISC-expressing organisms, primarily eukaryotes. Recently, a new generation of RNA biotechnologists have developed alternative mechanisms for controlling gene expression through RNA, and so made possible RNA-mediated gene knockdowns in bacteria. Here we describe a method for silencing gene expression in E. coli that functionally resembles RNAi. In this system a synthetic phagemid is designed to express sRNA, which may designed to target any sequence. The expression construct is delivered to a population of E. coli cells with non-lytic M13 phage, after which it is able to stably replicate as a plasmid. Antisense recognition and silencing of the target mRNA is mediated by the Hfq protein, endogenous to E. coli. This protocol includes methods for designing the antisense sRNA, constructing the phagemid vector, packaging the phagemid into M13 bacteriophage, preparing a live cell population for infection, and performing the infection itself. The fluorescent protein mKate2 and the antibiotic resistance gene chloramphenicol acetyltransferase (CAT) are targeted to generate representative data and to quantify knockdown effectiveness.

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

We describe a method to knock down gene expression in a growing population of E. coli cells using sequence-targeted sRNA expression cassettes delivered by an M13 phagemid vector.